Clinical Trial Update: Tranexamic Acid in Radical Resection and Endoprosthetic Reconstruction [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating tranexamic acid during radical resection and endoprosthetic reconstruction for musculoskeletal cancers was terminated, with results pos…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bone Cancer
• Soft Tissue Sarcoma

Drugs mentioned

• TRANEXAMIC ACID (TRANEXAMIC ACID)

Snippet

Sponsor: University of Kansas Medical Center | Conditions: Musculoskeletal Cancer, Sarcoma,Soft Tissue | Phase 4 | Status: TERMINATED | Results posted: 2025-05-21